Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Autophagy drives osteogenic differentiation of human gingival mesenchymal stem cells.

Vidoni C, Ferraresi A, Secomandi E, Vallino L, Gardin C, Zavan B, Mortellaro C, Isidoro C.

Cell Commun Signal. 2019 Aug 19;17(1):98. doi: 10.1186/s12964-019-0414-7.

2.

Stimulation of bone formation by monocyte-activator functionalized graphene oxide in vivo.

Bordoni V, Reina G, Orecchioni M, Furesi G, Thiele S, Gardin C, Zavan B, Cuniberti G, Bianco A, Rauner M, Delogu LG.

Nanoscale. 2019 Nov 7;11(41):19408-19421. doi: 10.1039/c9nr03975a. Epub 2019 Aug 6.

PMID:
31386739
3.

Direct ink writing of porous titanium (Ti6Al4V) lattice structures.

Elsayed H, Rebesan P, Giacomello G, Pasetto M, Gardin C, Ferroni L, Zavan B, Biasetto L.

Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109794. doi: 10.1016/j.msec.2019.109794. Epub 2019 May 25.

PMID:
31349412
4.

Characterization of Dermal Stem Cells of Diabetic Patients.

Ferroni L, Gardin C, Dalla Paola L, Campo G, Cimaglia P, Bellin G, Pinton P, Zavan B.

Cells. 2019 Jul 16;8(7). pii: E729. doi: 10.3390/cells8070729.

5.

Bovine pericardium membrane as new tool for mesenchymal stem cells commitment.

Ferroni L, Gardin C, Bellin G, Vindigni V, Mortellaro C, Zavan B.

J Tissue Eng Regen Med. 2019 Oct;13(10):1805-1814. doi: 10.1002/term.2931. Epub 2019 Aug 15.

PMID:
31291062
6.

Metal Nanoparticles Released from Dental Implant Surfaces: Potential Contribution to Chronic Inflammation and Peri-Implant Bone Loss.

Bressan E, Ferroni L, Gardin C, Bellin G, Sbricoli L, Sivolella S, Brunello G, Schwartz-Arad D, Mijiritsky E, Penarrocha M, Penarrocha D, Taccioli C, Tatullo M, Piattelli A, Zavan B.

Materials (Basel). 2019 Jun 25;12(12). pii: E2036. doi: 10.3390/ma12122036.

7.

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.

Astorgues-Xerri L, Vázquez R, Odore E, Rezai K, Kahatt C, Mackenzie S, Bekradda M, Coudé MM, Dombret H, Gardin C, Lokiec F, Raymond E, Noel K, Cvitkovic E, Herait P, Bertoni F, Riveiro ME.

Leuk Lymphoma. 2019 Dec;60(12):3067-3070. doi: 10.1080/10428194.2019.1617860. Epub 2019 Jun 17. No abstract available.

PMID:
31204545
8.

Effects of novel antidepressant drugs on mesenchymal stem cell physiology.

Ferroni L, Gardin C, Bellin G, Vindigni V, Pavan C, Zavan B.

Biomed Pharmacother. 2019 Jun;114:108853. doi: 10.1016/j.biopha.2019.108853. Epub 2019 Apr 12.

9.

Autologous Fat Transfer for Facial Augmentation: Surgery and Regeneration.

Clauser L, Zavan B, Galiè M, Di Vittorio L, Gardin C, Bianchi AE.

J Craniofac Surg. 2019 May/Jun;30(3):682-685. doi: 10.1097/SCS.0000000000005257.

PMID:
30817527
10.

Exosome in Cardiovascular Diseases: A Complex World Full of Hope.

Bellin G, Gardin C, Ferroni L, Chachques JC, Rogante M, Mitrečić D, Ferrari R, Zavan B.

Cells. 2019 Feb 17;8(2). pii: E166. doi: 10.3390/cells8020166. Review.

11.

Therapeutic Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver Disease.

Gardin C, Ferroni L, Bellin G, Rubini G, Barosio S, Zavan B.

Int J Mol Sci. 2018 Dec 15;19(12). pii: E4064. doi: 10.3390/ijms19124064.

12.

Bioactive Sphene-Based Ceramic Coatings on cpTi Substrates for Dental Implants: An In Vitro Study.

Elsayed H, Brunello G, Gardin C, Ferroni L, Badocco D, Pastore P, Sivolella S, Zavan B, Biasetto L.

Materials (Basel). 2018 Nov 9;11(11). pii: E2234. doi: 10.3390/ma11112234.

13.

In Vitro Effect of Bromelain on the Regenerative Properties of Mesenchymal Stem Cells.

Ghensi P, Cucchi A, Bonaccorso A, Ferroni L, Gardin C, Mortellaro C, Zavan B.

J Craniofac Surg. 2019 Jun;30(4):1064-1067. doi: 10.1097/SCS.0000000000004862.

PMID:
30358745
14.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

Lambert J, Pautas C, Terré C, Raffoux E, Turlure P, Caillot D, Legrand O, Thomas X, Gardin C, Gogat-Marchant K, Rubin SD, Benner RJ, Bousset P, Preudhomme C, Chevret S, Dombret H, Castaigne S.

Haematologica. 2019 Jan;104(1):113-119. doi: 10.3324/haematol.2018.188888. Epub 2018 Aug 3.

15.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.

Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.

16.

Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.

Kelaidi C, Braun T, Arana R, Marceau-Renaut A, Lazarian G, Soret J, Cereja S, Letestu R, Eclache V, Lusina D, Baran-Marszak F, Ades L, Preudhomme C, Martin A, Fenaux P, Gardin C.

Leuk Res. 2018 Aug;71:67-74. doi: 10.1016/j.leukres.2018.05.007. Epub 2018 May 29.

PMID:
30025278
17.

Biocompatibility and antibacterial properties of zirconium nitride coating on titanium abutments: An in vitro study.

Brunello G, Brun P, Gardin C, Ferroni L, Bressan E, Meneghello R, Zavan B, Sivolella S.

PLoS One. 2018 Jun 26;13(6):e0199591. doi: 10.1371/journal.pone.0199591. eCollection 2018.

18.

Graphene-Based Nanomaterials for Tissue Engineering in the Dental Field.

Guazzo R, Gardin C, Bellin G, Sbricoli L, Ferroni L, Ludovichetti FS, Piattelli A, Antoniac I, Bressan E, Zavan B.

Nanomaterials (Basel). 2018 May 20;8(5). pii: E349. doi: 10.3390/nano8050349. Review.

19.

Pulsed electromagnetic fields increase osteogenetic commitment of MSCs via the mTOR pathway in TNF-α mediated inflammatory conditions: an in-vitro study.

Ferroni L, Gardin C, Dolkart O, Salai M, Barak S, Piattelli A, Amir-Barak H, Zavan B.

Sci Rep. 2018 Mar 23;8(1):5108. doi: 10.1038/s41598-018-23499-9.

20.

Autologous Fat Transfer for Facial Augmentation and Regeneration: Role of Mesenchymal Stem Cells.

Clauser L, Lucchi A, Tocco-Tussardi I, Gardin C, Zavan B.

Atlas Oral Maxillofac Surg Clin North Am. 2018 Mar;26(1):25-32. doi: 10.1016/j.cxom.2017.10.002. Review. No abstract available.

PMID:
29362068
21.

The Biological Properties of OGI Surfaces Positively Act on Osteogenic and Angiogenic Commitment of Mesenchymal Stem Cells.

Ghensi P, Bressan E, Gardin C, Ferroni L, Soldini MC, Mandelli F, Soldini C, Zavan B.

Materials (Basel). 2017 Nov 17;10(11). pii: E1321. doi: 10.3390/ma10111321.

22.

Treatment of diabetic foot ulcers with Therapeutic Magnetic Resonance (TMR®) improves the quality of granulation tissue.

Ferroni L, Gardin C, De Pieri A, Sambataro M, Seganfreddo E, Goretti C, Iacopi E, Zavan B, Piaggesi A.

Eur J Histochem. 2017 Aug 7;61(3):2800. doi: 10.4081/ejh.2017.2800.

23.

Porcine Bone Scaffolds Adsorb Growth Factors Secreted by MSCs and Improve Bone Tissue Repair.

Mijiritsky E, Ferroni L, Gardin C, Bressan E, Zanette G, Piattelli A, Zavan B.

Materials (Basel). 2017 Sep 8;10(9). pii: E1054. doi: 10.3390/ma10091054.

24.

Release of VEGF from Dental Implant Improves Osteogenetic Process: Preliminary In Vitro Tests.

Zavan B, Ferroni L, Gardin C, Sivolella S, Piattelli A, Mijiritsky E.

Materials (Basel). 2017 Sep 8;10(9). pii: E1052. doi: 10.3390/ma10091052.

25.

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Falantes J, Pleyer L, Thépot S, Almeida AM, Maurillo L, Martínez-Robles V, Stauder R, Itzykson R, Pinto R, Venditti A, Bargay J, Burgstaller S, Martínez MP, Seegers V, Cortesão E, Foncillas MÁ, Gardin C, Montesinos P, Musto P, Fenaux P, Greil R, Sanz MA, Ramos F; European ALMA + Investigators.

Leuk Lymphoma. 2018 May;59(5):1113-1120. doi: 10.1080/10428194.2017.1365854. Epub 2017 Aug 24.

PMID:
28838276
26.

Bioactive Glass-Ceramic Scaffolds from Novel 'Inorganic Gel Casting' and Sinter-Crystallization.

Elsayed H, Rincón Romero A, Ferroni L, Gardin C, Zavan B, Bernardo E.

Materials (Basel). 2017 Feb 13;10(2). pii: E171. doi: 10.3390/ma10020171.

27.

Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML).

Braun T, Gardin C.

Expert Opin Investig Drugs. 2017 Jul;26(7):803-811. doi: 10.1080/13543784.2017.1335711. Epub 2017 Jun 9. Review.

PMID:
28541716
28.

Hypomethylating Agents as a Therapy for AML.

Gardin C, Dombret H.

Curr Hematol Malig Rep. 2017 Feb;12(1):1-10. doi: 10.1007/s11899-017-0363-4. Review.

PMID:
28286907
29.

Osteo Growth Induction titanium surface treatment reduces ROS production of mesenchymal stem cells increasing their osteogenic commitment.

Ghensi P, Bressan E, Gardin C, Ferroni L, Ruffato L, Caberlotto M, Soldini C, Zavan B.

Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:389-398. doi: 10.1016/j.msec.2016.12.032. Epub 2016 Dec 9.

PMID:
28254309
30.

Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.

Rimessi A, Pavan C, Ioannidi E, Nigro F, Morganti C, Brugnoli A, Longo F, Gardin C, Ferroni L, Morari M, Vindigni V, Zavan B, Pinton P.

Neuropsychopharmacology. 2017 Jun;42(7):1491-1501. doi: 10.1038/npp.2017.20. Epub 2017 Jan 27.

31.

Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.

Ades L, Prebet T, Stamatoullas A, Recher C, Guieze R, Raffoux E, Bouabdallah K, Hunault M, Wattel E, Stalnikiewicz L, Toma A, Dombret H, Vey N, Sebert M, Gardin C, Chaffaut C, Chevret S, Fenaux P.

Haematologica. 2017 Apr;102(4):728-735. doi: 10.3324/haematol.2016.151894. Epub 2016 Dec 29.

32.

HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimens.

Arana R, Lusina D, Braun T, Letestu R, Gardin C, Martin A.

J Clin Pathol. 2016 Oct;69(10):933-7. doi: 10.1136/jclinpath-2016-203850. Epub 2016 Aug 2.

PMID:
27484914
33.

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.

Grignano E, Mekinian A, Braun T, Liozon E, Hamidou M, Decaux O, Puéchal X, Kahn JE, Schoindre Y, Rossignol J, Lortholary O, Lioger B, Hermine O, Park S, Ades L, Montestruc F, Ricard L, Gardin C, Fenaux P, Fain O; GFM, SNFMI and CRI.

Leuk Res. 2016 Aug;47:136-41. doi: 10.1016/j.leukres.2016.05.013. Epub 2016 Jun 2.

34.

Non-Washed Resorbable Blasting Media (NWRBM) on Titanium Surfaces could Enhance Osteogenic Properties of MSCs through Increase of miRNA-196a And VCAM1.

Gardin C, Ferroni L, Piattelli A, SIvolella S, Zavan B, Mijiritsky E.

Stem Cell Rev Rep. 2016 Oct;12(5):543-552.

PMID:
27318850
35.

A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.

Thépot S, Ben Abdelali R, Chevret S, Renneville A, Beyne-Rauzy O, Prébet T, Park S, Stamatoullas A, Guerci-Bresler A, Cheze S, Tertian G, Choufi B, Legros L, Bastié JN, Delaunay J, Chaury MP, Sanhes L, Wattel E, Dreyfus F, Vey N, Chermat F, Preudhomme C, Fenaux P, Gardin C; Groupe Francophone des Myélodysplasies (GFM).

Haematologica. 2016 Aug;101(8):918-25. doi: 10.3324/haematol.2015.140988. Epub 2016 May 26.

36.

Powder-based 3D printing for bone tissue engineering.

Brunello G, Sivolella S, Meneghello R, Ferroni L, Gardin C, Piattelli A, Zavan B, Bressan E.

Biotechnol Adv. 2016 Sep-Oct;34(5):740-753. doi: 10.1016/j.biotechadv.2016.03.009. Epub 2016 Apr 13. Review.

PMID:
27086202
37.

Adipose-Derived Stem Cells as a Tool for Dental Implant Osseointegration: an Experimental Study in the Dog.

Bressan E, Botticelli D, Sivolella S, Bengazi F, Guazzo R, Sbricoli L, Ricci S, Ferroni L, Gardin C, Velez JU, Zavan B.

Int J Mol Cell Med. 2015 Fall;4(4):197-208.

38.

Mesenchymal Stem Cells Increase Neo-Angiogenesis and Albumin Production in a Liver Tissue-Engineered Engraftment.

Carraro A, Buggio M, Gardin C, Tedeschi U, Ferroni L, Zavan PB.

Int J Mol Sci. 2016 Mar 12;17(3):374. doi: 10.3390/ijms17030374.

39.

Pulsed magnetic therapy increases osteogenic differentiation of mesenchymal stem cells only if they are pre-committed.

Ferroni L, Tocco I, De Pieri A, Menarin M, Fermi E, Piattelli A, Gardin C, Zavan B.

Life Sci. 2016 May 1;152:44-51. doi: 10.1016/j.lfs.2016.03.020. Epub 2016 Mar 12.

PMID:
26979772
40.

Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Fraison JB, Mekinian A, Grignano E, Kahn JE, Arlet JB, Decaux O, Denis G, Buchdahl AL, Omouri M, Maigne G, Aouba A, Leon N, Berthier S, Liozon E, Park S, Gardin C, Lortholary O, Rossignol J, Fenaux P, Fain O, Braun T.

Leuk Res. 2016 Apr;43:13-7. doi: 10.1016/j.leukres.2016.02.005. Epub 2016 Feb 20.

41.

Graphene in Regenerative Medicine: Focus on Stem Cells and Neuronal Differentiation.

Gardin C, Piattelli A, Zavan B.

Trends Biotechnol. 2016 Jun;34(6):435-437. doi: 10.1016/j.tibtech.2016.01.006. Epub 2016 Feb 12. Review.

PMID:
26879187
42.

Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid Leukemia.

Vidal-Petiot E, Rea D, Serrano F, Stehlé T, Gardin C, Rousselot P, Peraldi MN, Flamant M.

Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):169-74. doi: 10.1016/j.clml.2015.12.001. Epub 2015 Dec 20.

PMID:
26795084
43.

An update of current treatments for adult acute myeloid leukemia.

Dombret H, Gardin C.

Blood. 2016 Jan 7;127(1):53-61. doi: 10.1182/blood-2015-08-604520. Epub 2015 Dec 10. Review.

44.

Novel Nanotechnologies for Brain Cancer Therapeutics and Imaging.

Ferroni L, Gardin C, Della Puppa A, Sivolella S, Brunello G, Scienza R, Bressan E, D'Avella D, Zavan B.

J Biomed Nanotechnol. 2015 Nov;11(11):1899-912. Review.

PMID:
26554151
45.

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion.

Toma A, Kosmider O, Chevret S, Delaunay J, Stamatoullas A, Rose C, Beyne-Rauzy O, Banos A, Guerci-Bresler A, Wickenhauser S, Caillot D, Laribi K, De Renzis B, Bordessoule D, Gardin C, Slama B, Sanhes L, Gruson B, Cony-Makhoul P, Chouffi B, Salanoubat C, Benramdane R, Legros L, Wattel E, Tertian G, Bouabdallah K, Guilhot F, Taksin AL, Cheze S, Maloum K, Nimuboma S, Soussain C, Isnard F, Gyan E, Petit R, Lejeune J, Sardnal V, Renneville A, Preudhomme C, Fontenay M, Fenaux P, Dreyfus F.

Leukemia. 2016 Apr;30(4):897-905. doi: 10.1038/leu.2015.296. Epub 2015 Oct 26.

46.

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.

Debarri H, Lebon D, Roumier C, Cheok M, Marceau-Renaut A, Nibourel O, Geffroy S, Helevaut N, Rousselot P, Gruson B, Gardin C, Chretien ML, Sebda S, Figeac M, Berthon C, Quesnel B, Boissel N, Castaigne S, Dombret H, Renneville A, Preudhomme C.

Oncotarget. 2015 Dec 8;6(39):42345-53. doi: 10.18632/oncotarget.5645.

47.

A Novel In Vitro Technique for Assessing Dental Implant Osseointegration.

Sivolella S, Brunello G, Ferroni L, Berengo M, Meneghello R, Savio G, Piattelli A, Gardin C, Zavan B.

Tissue Eng Part C Methods. 2016 Feb;22(2):132-141. Epub 2015 Nov 19.

PMID:
26443415
48.

Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.

Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, Kahn JE, Hamidou M, Park S, Puéchal X, Toussirot E, Falgarone G, Launay D, Morel N, Trouiller S, Mathian A, Gombert B, Schoindre Y, Lioger B, De Wazieres B, Amoura Z, Buchdaul AL, Georgin-Lavialle S, Dion J, Madaule S, Raffray L, Cathebras P, Piette JC, Rose C, Ziza JM, Lortholary O, Montestruc F, Omouri M, Denis G, Rossignol J, Nimubona S, Adès L, Gardin C, Fenaux P, Fain O.

Rheumatology (Oxford). 2016 Feb;55(2):291-300. doi: 10.1093/rheumatology/kev294. Epub 2015 Sep 8.

PMID:
26350487
49.

Persistence of CD34 Stem Marker in Human Lipoma: Searching for Cancer Stem Cells.

Zavan B, De Francesco F, D'Andrea F, Ferroni L, Gardin C, Salzillo R, Nicoletti G, Ferraro GA.

Int J Biol Sci. 2015 Jul 18;11(10):1127-39. doi: 10.7150/ijbs.11946. eCollection 2015.

50.

Decellularization and Delipidation Protocols of Bovine Bone and Pericardium for Bone Grafting and Guided Bone Regeneration Procedures.

Gardin C, Ricci S, Ferroni L, Guazzo R, Sbricoli L, De Benedictis G, Finotti L, Isola M, Bressan E, Zavan B.

PLoS One. 2015 Jul 20;10(7):e0132344. doi: 10.1371/journal.pone.0132344. eCollection 2015.

Supplemental Content

Loading ...
Support Center